Coverage requirement of medical services and prescription medications for the treatment of dementia

Summary

The bill adds a new statute that obligates health‑plan companies to cover any medical service or prescription drug approved by the FDA for treating or slowing dementia, as well as related diagnostic testing. It also prohibits insurers from using step‑therapy protocols for those covered services. The changes take effect on January 1, 2027 for plans issued or renewed after that date.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share